Antigen presentation by non-immune B-cell hybridoma clones: presentation of synthetic antigenic sites reveals clones that exhibit no specificity and clones that present only one epitope
- PMID: 2479600
- DOI: 10.3109/08820138909045785
Antigen presentation by non-immune B-cell hybridoma clones: presentation of synthetic antigenic sites reveals clones that exhibit no specificity and clones that present only one epitope
Abstract
Recently, we reported the preparation and antigen-presenting properties of hybridoma B-cell clones obtained after fusing non-secreting, non-antigen presenting Balb/c 653-myeloma cells with non-immune SJL spleen cells. It was found that antigen presentation at the clonal level can be specific or non-specific, depending on the particular B-cell clone. In the present work, one specific and one general presenter B-cell clones were tested for their epitope presentation ability to SJL T-cells that were specific to lysozyme or myoglobin. B-cell clone A1G12, a general presenter which presented both lysozyme and myoglobin to their respective T-cell lines, was found to present all five myoglobin epitopes while clone A1L16, a lysozyme specific presenter presented only one of the three epitopes of lysozyme. The latter reveals a hitherto unknown submolecular specificity (to a given epitope within a protein) for antigen presenting cells at the clonal level. Therefore, the specificity of T-cell recognition does not only derive from the T-cell but may also be dependent on the epitope specificity of the antigen-presenting B-cell.
Similar articles
-
Presentation of antigen to T lymphocytes by non-immune B-cell hybridoma clones: evidence for specific and non-specific presentation.Immunol Invest. 1989 Jun;18(5):651-6. doi: 10.3109/08820138909057752. Immunol Invest. 1989. PMID: 2786844
-
Presentation of antigen to T lymphocytes by non-immune B-cell hybridoma clones: evidence for specific and non-specific presentation.Immunol Invest. 1988 Aug-Oct;17(6-7):615-20. doi: 10.3109/08820138809030593. Immunol Invest. 1988. PMID: 3266192
-
Production of T-T hybrids from T cell clones. Direct comparison between cloned T cells and T hybridoma cells derived from them.J Immunol. 1988 Jul 1;141(1):71-8. J Immunol. 1988. PMID: 2454265
-
Molecular aspects of the role of class II MHC molecules in antigen presentation to T cells.Year Immunol. 1988;3:161-78. Year Immunol. 1988. PMID: 2450430 Review. No abstract available.
-
Clonal sketches of the immune response.EMBO J. 1988 Oct;7(10):2945-51. doi: 10.1002/j.1460-2075.1988.tb03156.x. EMBO J. 1988. PMID: 3053159 Free PMC article. Review. No abstract available.
Cited by
-
Vaccines for cancer prevention: exploring opportunities and navigating challenges.Nat Rev Drug Discov. 2025 Feb;24(2):134-150. doi: 10.1038/s41573-024-01081-5. Epub 2024 Dec 2. Nat Rev Drug Discov. 2025. PMID: 39622986 Review.
-
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells.Mol Cancer. 2023 Aug 30;22(1):141. doi: 10.1186/s12943-023-01844-5. Mol Cancer. 2023. PMID: 37649123 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources